Healthcare >> Analyst Interviews >> May 8, 2002

Innovative Biopharmaceutical Companies: Ed Gordon – Punk Ziegel & Co

ED GORDON is a Managing Director and co-Head of Punk Ziegel & Company's healthcare practice that is focused on biotechnology, genomics, and healthcare information systems companies. Prior to joining Punk Ziegel, he was a Managing Director in SG Cowen's Health Investment Banking Group, focusing on healthcare services and healthcare information systems companies inclusive). Mr. Gordon started his corporate finance career at ING Barings (formerly Furman Selz). His clients included leading hospital and managed care companies. Before moving into investment banking, He led the Health Care Services Research effort at Morgan Stanley. During his career there, both Institutional Investor magazine and the Annual Greenwich Survey of Institutional Investors ranked him among the top analysts covering facility-based healthcare management companies (hospitals, nursing homes, physician practice management and ambulatory surgery centers) and managed care companies. Mr. Gordon received his BA in Economics and an MBA in Finance and Economics from the University of Pittsburgh. Profile
TWST: What is the healthcare practice at Punk Ziegel & Company?

Mr. Gordon: Punk Ziegel's healthcare practice is focused

singularly on innovative biopharmaceutical companies. We have